Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma

Experimental Cell Research

Volumn 318, Issue 13, 2012, Pages 1517-1527

  Fullár, Alexandra ^a,b   Kovalszky, Ilona ^a   Bitsche, Mario ^b   Romani, Angela ^b   Schartinger, Volker Hans ^b   Sprinzl, Georg Mathias ^b   Riechelmann, Herbert ^b   Dudás, József ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Co culture insert; HNSCC; Matrix remodeling; Metastasis

Indexed keywords

ALPHAVBETA6 INTEGRIN; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER CELL; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOTHESIS; MOLECULAR INTERACTION; MOUTH SQUAMOUS CELL CARCINOMA; PARACRINE SIGNALING; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

EID: 84862000373     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.03.023     Document Type: Article

References (47)

1. Mamelle G., Pampurik J., Luboinski B., Lancar R., Lusinchi A., Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am. J. Surg. 1994, 168:494-498.
2. Hensen E.F., De Herdt M.J., Goeman J.J., Oosting J., Smit V.T., Cornelisse C.J., Baatenburg de Jong R.J. Gene-expression of metastasized versus non-metastasized primary head and neck squamous cell carcinomas: a pathway-based analysis. BMC Cancer 2008, 8:168.
3. Villaret D.B., Wang T., Dillon D., Xu J., Sivam D., Cheever M.A., Reed S.G. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000, 110:374-381.
4. El Badry A.A., El-Fadle A.A., El-Balshy A.L. Tissue inhibitor of matrix metalloproteinase-2 in nasopharyngeal carcinoma. MedGenMed 2007, 9:3.
5. Ruokolainen H., Paakko P., Turpeenniemi-Hujanen T. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Clin. Cancer Res. 2005, 11:3257-3264.
6. Orimo A., Weinberg R.A. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006, 5:1597-1601.
7. Higashikawa K., Yoneda S., Taki M., Shigeishi H., Ono S., Tobiume K., Kamata N. Gene expression profiling to identify genes associated with high-invasiveness in human squamous cell carcinoma with epithelial-to-mesenchymal transition. Cancer Lett. 2008, 264:256-264.
8. Paterlini-Brechot P., Benali N.L. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007, 253:180-204.
9. Hoot K.E., Lighthall J., Han G., Lu S.L., Li A., Ju W., Kulesz-Martin M., Bottinger E., Wang X.J. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J. Clin. Invest. 2008, 118:2722-2732.
10. Casarsa C., Bassani N., Ambrogi F., Zabucchi G., Boracchi P., Biganzoli E., Coradini D. Epithelial-to-mesenchymal transition, cell polarity and stemness-associated features in malignant pleural mesothelioma. Cancer Lett. 2011, 302:136-143.
11. Dudas J., Bitsche M., Schartinger V., Falkeis C., Sprinzl G.M., Riechelmann H. Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells. Oral Oncol. Feb. 2011, 47(2):98-103.
12. Dudas J., Fullar A., Bitsche M., Schartinger V., Kovalszky I., Sprinzl G.M., Riechelmann H. Tumor-produced, active Interleukin-1 beta regulates gene expression in carcinoma-associated fibroblasts. Exp. Cell Res. Sep. 10 2011, 317(15):2222-2229.
13. Docheva D., Padula D., Popov C., Weishaupt P., Pragert M., Miosge N., Hickel R., Bocker W., Clausen-Schaumann H., Schieker M. Establishment of immortalized periodontal ligament progenitor cell line and its behavioural analysis on smooth and rough titanium surface. Eur. Cell. Mater. 2010, 19:228-241.
14. Miyazawa K., Mori A., Okudaira H. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by glucocorticoids. J. Biochem. 1998, 124:1130-1137.
15. Yang C.M., Luo S.F., Hsieh H.L., Chi P.L., Lin C.C., Wu C.C., Hsiao L.D. Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB. J. Cell. Physiol. 2010, 224:516-526.
16. Dudas J., Mansuroglu T., Moriconi F., Haller F., Wilting J., Lorf T., Fuzesi L., Ramadori G. Altered regulation of Prox1-gene-expression in liver tumors. BMC Cancer 2008, 8:92.
17. Haller F., Kulle B., Schwager S., Gunawan B., von Heydebreck A., Sultmann H., Fuzesi L. Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization. Anal. Biochem. 2004, 335:1-9.
18. Elliott S.F., Coon C.I., Hays E., Stadheim T.A., Vincenti M.P. Bcl-3 is an interleukin-1-responsive gene in chondrocytes and synovial fibroblasts that activates transcription of the matrix metalloproteinase 1 gene. Arthritis Rheum. 2002, 46:3230-3239.
19. Moran A., Iniesta P., de Juan C., Gonzalez-Quevedo R., Sanchez-Pernaute A., Diaz-Rubio E., Cajal S., Torres A., Balibrea J.L., Benito M. Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors. Cancer Res. 2002, 62:3855-3860.
20. Sasaki H., Yukiue H., Moiriyama S., Kobayashi Y., Nakashima Y., Kaji M., Kiriyama M., Fukai I., Yamakawa Y., Fujii Y. Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J. Surg. Res. 2001, 101:242-247.
21. Ueda M., Yamashita Y., Takehara M., Terai Y., Kumagai K., Ueki K., Kanda K., Hung Y.C., Ueki M. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. Gynecol. Endocrinol. 2002, 16:391-402.
22. Winter S., Kohl A., Huppertz A., Herold-Mende C., Wiest T., Komposch G., Tomakidi P. Expression of mRNAs encoding for growth factors, ECM molecules, and MMP13 in mono-cultures and co-cultures of human periodontal ligament fibroblasts and alveolar bone cells. Cell Tissue Res. 2005, 319:467-478.
23. Sasaki K., Takagi M., Mandelin J., Takei I., Santavirta S., Ida H., Ogino T., Konttinen Y.T. Quantitative analysis of mRNA expression of TIMPs in the periprosthetic interface tissue of loose hips by real-time PCR system. J. Biomed. Mater. Res. 2001, 58:605-612.
24. Yanai Y., Micallef M.J., Yamamoto S., Yamamoto K., Yamauchi H., Ikegami H., Kurimoto M. Expression profiling of tumor necrosis factor alpha-induced apoptosis-associated genes in human solid tumor cell lines. Anticancer Res. 2003, 23:2339-2348.
25. Hough C.D., Cho K.R., Zonderman A.B., Schwartz D.R., Morin P.J. Coordinately up-regulated genes in ovarian cancer. Cancer Res. 2001, 61:3869-3876.
26. Wenghoefer M., Pantelis A., Najafi T., Deschner J., Allam J.P., Novak N., Reich R., Martini M., Berge S., Fischer H.P., Jepsen S., Winter J. Gene expression of oncogenes, antimicrobial peptides, and cytokines in the development of oral leukoplakia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2010, 110:351-356.
27. Rogojina A.T., Orr W.E., Song B.K., Geisert E.E. Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines. Mol. Vis. 2003, 9:482-496.
28. Dudas J., Ramadori G., Knittel T., Neubauer K., Raddatz D., Egedy K., Kovalszky I. Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate. Biochem. J. 2000, 350(Pt 1):245-251.
29. Tse W.K., Au D.W., Wong C.K. Characterization of ion channel and transporter mRNA expressions in isolated gill chloride and pavement cells of seawater acclimating eels. Biochem. Biophys. Res. Commun. 2006, 346:1181-1190.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
31. Baghy K., Dezso K., Laszlo V., Fullar A., Peterfia B., Paku S., Nagy P., Schaff Z., Iozzo R.V., Kovalszky I. Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Lab. Invest. 2011, 91:439-451.
32. Thomas G.T., Lewis M.P., Speight P.M. Matrix metalloproteinases and oral cancer. Oral Oncol. 1999, 35:227-233.
33. Ge G., Greenspan D.S. BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J. Cell Biol. 2006, 175:111-120.
34. Tokumaru Y., Fujii M., Otani Y., Kameyama K., Imanishi Y., Igarashi N., Kanzaki J. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts. Cancer Lett. 2000, 150:15-21.
35. Kusukawa J., Sasaguri Y., Shima I., Kameyama T., Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am. J. Clin. Pathol. 1993, 99:18-23.
36. Imanishi Y., Fujii M., Tokumaru Y., Tomita T., Kanke M., Kanzaki J., Kameyama K., Otani Y., Sato H. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum. Pathol. 2000, 31:895-904.
37. de Vicente J.C., Fresno M.F., Villalain L., Vega J.A., Hernandez V.G. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol. 2005, 41:283-293.
38. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006, 25:9-34.
39. Lin S.C., Lo S.S., Liu C.J., Chung M.Y., Huang J.W., Chang K.W. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J. Oral Pathol. Med. 2004, 33:405-409.
40. Ishikawa S., Takenaka K., Yanagihara K., Miyahara R., Kawano Y., Otake Y., Hasegawa S., Wada H., Tanaka F. Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer. Clin. Cancer Res. 2004, 10:6579-6585.
41. Hayashido Y., Urabe K., Yoshioka Y., Kitano H., Okamoto T., Matsuya T. Participation of fibroblasts in MMP-2 binding and activation on the surface of oral squamous cell carcinoma cells. Int. J. Oncol. 2003, 22:657-662.
42. Yang Y., Dang D., Atakilit A., Schmidt B., Regezi J., Li X., Eisele D., Ellis D., Ramos D.M. Specific alpha v integrin receptors modulate K1735 murine melanoma cell behavior. Biochem. Biophys. Res. Commun. 2003, 308:814-819.
43. Lin S.W., Ke F.C., Hsiao P.W., Lee P.P., Lee M.T., Hwang J.J. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. Exp. Cell Res. 2007, 313:602-613.
44. Desai B., Rogers M.J., Chellaiah M.A. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol. Cancer 2007, 6:18.
45. Baker A.H., Edwards D.R., Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 2002, 115:3719-3727.
46. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92:827-839.
47. Nagase H. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res. 1998, 8:179-186.